The two drug companies have agreed to pay $54 million to settle San Francisco’s opioid trial on Tuesday, but closing arguments continue against a third defendant, Walgreens.
Allergan, Teva Settle Opioid Trial As Closing Arguments Begin in San Francisco
Leave a Reply